Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00984841 · ClinicalTrials.gov registry record · NA

Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

A NA study of Diabetes Mellitus, sponsored by Scranton-Temple Residency Program.

Completed
Registry status
NA
Development phase
467
Enrollment target
1
Study location

NCT00984841: Completed NA study of Diabetes Mellitus, sponsored by Scranton-Temple Residency Program.

NCT00984841 is a NA study of Diabetes Mellitus that has completed, run by Scranton-Temple Residency Program. The registered enrollment target is 467 participants, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00984841, a NA study of Diabetes Mellitus, has completed, sponsored by Scranton-Temple Residency Program.

COMPLETED
Registry status
NA
Development phase
467 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Conditions Studied

Interventions

  • OTHER Tailored letter

Study Locations (1)

Pennsylvania

  • Scranton-Temple Health Center - Scranton

Trial Details

FieldValue
Enrollment Target 467 participants
Start Date 2009-01
Est. Completion 2009-07
Phase NA

What the finished NCT00984841 record still lists

NCT00984841 is an interventional study that assigns participants to a tested intervention. The registered 467 participants enrollment target is mid-sized for trials with a published cap, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Tailored letter is the first listed.

NCT00984841 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00984841 about?

NCT00984841 is a clinical study titled "Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?". The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

What is the current status of trial NCT00984841?

This trial is currently completed. It is a NA study. The enrollment target is 467 participants. The study started on 2009-01. Estimated completion is 2009-07.

What conditions does trial NCT00984841 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00984841?

The interventions under investigation include: Tailored letter (OTHER).

Who is sponsoring clinical trial NCT00984841?

This trial is sponsored by Scranton-Temple Residency Program, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00984841 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00984841's enrollment target sits among peer trials

467 52nd of 208 higher than 157 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06456554 · 467 participants · NA

    Acellular Dermal Matrix Investigation in Breast Reconstruction

  • NCT03124303 · 468 participants

    Interventions for Postoperative Delirium: Biomarker-3

  • NCT03901924 · 468 participants · NA

    Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

  • NCT04482309 · 468 participants · Phase 2

    A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00984841, the US trial registry maintained by the National Library of Medicine. NCT00984841 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.